Top insider buys: Feb 17 – Feb 23, 2025

The largest open-market purchases company insiders reported on SEC Form 4 between Feb 17 – Feb 23, 2025.

Week 8, 2025

#	Company	Who bought	Shares	Value	Source
1	CMPO CompoSecure, Inc.	3 officers/directors Cluster buy Resolute Compo Holdings LLC, Thomas R. Knott, John D. Cote	699,210	$11.6M	SEC filings
2	MBX MBX Biosciences, Inc.	2 officers/directors Cluster buy Carl L. Gordon, ORBIMED ADVISORS LLC	381,344	$4.0M	SEC filings
3	WYNN WYNN RESORTS LTD	2 officers/directors Cluster buy Paul Albert Liu, Philip G. Satre	23,800	$2.2M	SEC filings
4	CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	2 officers/directors Cluster buy James C. Foster, Birgit Girshick	7,589	$1.3M	SEC filings
5	NE Noble Corp plc	2 officers/directors Cluster buy Richard B. Barker, Robert W. Eifler	20,568	$574K	SEC filings
6	FLNC Fluence Energy, Inc.	2 officers/directors Cluster buy Ahmed Pasha, Julian Nebreda	39,000	$250K	SEC filings
7	SLDB Solid Biosciences Inc.	3 separate filers Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, Adage Capital Management, L.P.	6,252,545	$26.1M	SEC filings
8	ATAI ATAI Life Sciences N.V.	Director Christian Angermayer	10,835,718	$22.8M	SEC filings
9	RCUS Arcus Biosciences, Inc.	10% Owner GILEAD SCIENCES, INC.	1,363,636	$15.0M	SEC filings
10	JBHT HUNT J B TRANSPORT SERVICES INC	Director James L. Robo	59,447	$10.0M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.